ANANDAMIDE DECREASES NALOXONE-PRECIPITATED WITHDRAWAL SIGNS IN MICE CHRONICALLY TREATED WITH MORPHINE

被引:98
作者
VELA, G [1 ]
RUIZGAYO, M [1 ]
FUENTES, JA [1 ]
机构
[1] UNIV COMPLUTENSE MADRID,SCH PHARM,DEPT PHARMACOL,E-28040 MADRID,SPAIN
关键词
ANANDAMIDE; TETRAHYDROCANNABINOL; MORPHINE WITHDRAWAL;
D O I
10.1016/0028-3908(95)00032-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effect of anandamide, a putative endogenous ligand of the cannabinoid receptor, has been studied in a naloxone-precipitated morphine withdrawal syndrome in mice. Animals were chronically treated with increasing doses of morphine (from 8 to 45 mg/kg) over 5 days or implanted with morphine pellets (72 hr). Typical signs of withdrawal (jumping and body weight loss) were examined after naloxone administration (1 mg/kg). In these conditions, anandamide (5 mg/kg, i.v.) decreased both the number of jumps, measured over 30 min (81.2% +/- 3.15 and 92.2% +/- 3.5 decrease in chronically administered morphine and pellet implanted mice, respectively), and the body weight loss at 30 and 60 min (30 min: 2.6% +/- 0.4 vs 4.4% +/- 0.2 and 3.7% +/- 0.4 vs 5.3% +/- 0.4; 60 min: 3.2% +/- 0.5 vs 5.0% +/- 0.4 and 4.1% +/- 0.5 vs 6.0% +/- 0.5 in chronically treated morphine and pellet implanted mice respectively) after naloxone administration. This suggests, as shown in the case of Delta(9)-tetrahydrocannabinol, a modulation by anandamide of pathways involved in the expression of physical signs of opioid dependence and support its role as an endogenous cannabinoid agonist.
引用
收藏
页码:665 / 668
页数:4
相关论文
共 18 条
[1]   ISOLATION AND STRUCTURE OF A BRAIN CONSTITUENT THAT BINDS TO THE CANNABINOID RECEPTOR [J].
DEVANE, WA ;
HANUS, L ;
BREUER, A ;
PERTWEE, RG ;
STEVENSON, LA ;
GRIFFIN, G ;
GIBSON, D ;
MANDELBAUM, A ;
ETINGER, A ;
MECHOULAM, R .
SCIENCE, 1992, 258 (5090) :1946-1949
[2]   FORMATION AND INACTIVATION OF ENDOGENOUS CANNABINOID ANANDAMIDE IN CENTRAL NEURONS [J].
DIMARZO, V ;
FONTANA, A ;
CADAS, H ;
SCHINELLI, S ;
CIMINO, G ;
SCHWARTZ, JC ;
PIOMELLI, D .
NATURE, 1994, 372 (6507) :686-691
[3]   PHARMACOLOGICAL ACTIVITY OF THE CANNABINOID RECEPTOR AGONIST, ANANDAMIDE, A BRAIN CONSTITUENT [J].
FRIDE, E ;
MECHOULAM, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 231 (02) :313-314
[4]   MARIJUANAS INTERACTION WITH BRAIN REWARD SYSTEMS - UPDATE 1991 [J].
GARDNER, EL ;
LOWINSON, JH .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1991, 40 (03) :571-580
[5]   MORPHINE-DEPENDENT RATS - BLOCKADE OF PRECIPITATED ABSTINENCE BY TETRAHYDROCANNABINOL [J].
HINE, B ;
FRIEDMAN, E ;
TORRELIO, M ;
GERSHON, S .
SCIENCE, 1975, 187 (4175) :443-445
[6]  
HINE B, 1975, LIFE SCI, V17, P857
[7]   1-DELTA9-TETRAHYDROCANNABINOL - NEUROCHEMICAL AND BEHAVIORAL EFFECTS IN MOUSE [J].
HOLTZMAN, D ;
LOVELL, RA ;
JAFFE, JH ;
FREEDMAN, DX .
SCIENCE, 1969, 163 (3874) :1464-&
[8]   NALOXONE-INDUCED OR POST-WITHDRAWAL ABSTINENCE SIGNS IN DELTA-9-TETRAHYDROCANNABINOL-TOLERANT RATS [J].
KAYMAKCALAN, S ;
AYHAN, IH ;
TULUNAY, FC .
PSYCHOPHARMACOLOGY, 1977, 55 (03) :243-249
[9]   DISTRIBUTION OF NEURONAL CANNABINOID RECEPTOR IN THE ADULT-RAT BRAIN - A COMPARATIVE RECEPTOR-BINDING AUTORADIOGRAPHY AND INSITU HYBRIDIZATION HISTOCHEMISTRY [J].
MAILLEUX, P ;
VANDERHAEGHEN, JJ .
NEUROSCIENCE, 1992, 48 (03) :655-668
[10]  
MALDONADO R, 1992, N-S ARCH PHARMACOL, V345, P466